MEDX ... anybody following? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MEDX ... anybody following?

MEDX 31.15

-0.3%

Nov 3 1:15 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Icebrg	6/17/2008 4:57:21 PM
	Read Replies (1) of 2240

US panel urges approval of J&J psoriasis drug Tue Jun 17, 2008 4:44pm EDT SILVER SPRING, Md., June 17 (Reuters) - A U.S. advisory panel unanimously recommended approval of Johnson & Johnson's (JNJ.N: Quote, Profile, Research, Stock Buzz) experimental drug ustekinumab to treat adults with moderate to severe cases of psoriasis. The Food and Drug Administration will consider the advice before making a final decision, which is expected by September. The FDA usually follows panel recommendations.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next